These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11080321)

  • 21. Effect of sotalol on ventricular fibrillation and defibrillation in humans.
    Dorian P; Newman D
    Am J Cardiol; 1993 Aug; 72(4):72A-79A. PubMed ID: 8346730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful defibrillation by disconnection of superior vena cava electrode for high defibrillation threshold: a case report].
    Matsushita K; Ishikawa T; Sumita S; Kobayashi T; Kawasaki N; Matsumoto K; Taima M; Uchino K; Kimura K; Umemura S
    J Cardiol; 2005 Jan; 45(1):27-32. PubMed ID: 15700927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
    Connolly SJ; Dorian P; Roberts RS; Gent M; Bailin S; Fain ES; Thorpe K; Champagne J; Talajic M; Coutu B; Gronefeld GC; Hohnloser SH;
    JAMA; 2006 Jan; 295(2):165-71. PubMed ID: 16403928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of nifekalant hydrochloride on the QT dispersion after direct-current defibrillation.
    Maeda K; Takagi M; Tatsumi H; Nakagawa E; Yoshiyama M
    Osaka City Med J; 2008 Jun; 54(1):11-9. PubMed ID: 18819261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions.
    Marchlinski FE; Zado ES; Deely MP; Saligan J; Ashar M; Nayak H
    Am J Cardiol; 1999 Nov; 84(9A):69R-75R. PubMed ID: 10568663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of patients requiring intravenous amiodarone to suppress hemodynamically destabilizing ventricular arrhythmias.
    Fogel RI; Herre JM; Kopelman HA; Kowey PR; Trohman RG; Fineberg N; Prystowsky EN
    Am Heart J; 2000 Apr; 139(4):690-5. PubMed ID: 10740153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant.
    Boriani G; Rapezzi C; Biffi M; Branzi A
    Int J Cardiol; 2002 May; 83(2):171-3. PubMed ID: 12007691
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship of amiodarone to postoperative complications of transthoracic implantation of automatic implantable cardioverter defibrillators.
    Calkins H; Bahu M; Shyr Y; Schork A; Bolling S; Kou W; Kirsch M; Morady F
    Panminerva Med; 1996 Jun; 38(2):89-97. PubMed ID: 8979740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation].
    Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F
    Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there an effect of amiodarone on the defibrillation threshold?
    Güldal M; Karaoguz R; Akalin H; Bayar M; Akyol T
    Jpn Heart J; 1993 Mar; 34(2):221-6. PubMed ID: 8315819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T wave alternans for predicting adverse effects of amiodarone in a patient with dilated cardiomyopathy.
    Matsuyama T; Tanno K; Kobayashi Y; Obara C; Ryu S; Adachi T; Ezumi H; Asano T; Miyata A; Koba S; Baba T; Katagiri T
    Jpn Circ J; 2001 May; 65(5):468-70. PubMed ID: 11348056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
    Marill KA; deSouza IS; Nishijima DK; Stair TO; Setnik GS; Ruskin JN
    Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.